Neural Galaxy, a global leading brain science company. Jointly founded in July 2019 by Professor Hesheng Liu of Harvard Medical School, Guoping Feng and Robert Desimone at MIT, and Mr. Coach Wei. Neural Galaxy's mission is to solve brain disorders. Neural Galaxy announced its $6.2M Angel round financing and over $15M Pre-A round financing. With plus rounds and the A round financing over $75M, the startup has raised more than approximate $100M. Neural Galaxy has successfully solved a significant neuroscience challenge. It has developed the world's first and the only “personalized Brain Functional Sectors” technology (pBFS), reliably and accurately mapping over 200 functional parcellations of an individual brain. In 2020, Neural Galaxy released the world's first "Personalized Brain Computing Platform", enabling doctors to investigate individual-level brain functional issues from observing neural circuits and neural networks clinically for the first time. Its innovative therapy, POINT therapy, achieved individual-level precise intervention of brain disorder with a non-invasive "brain-computer interaction" approach to read, decode and write brain signals. Neural Galaxy has achieved significant positive treatment outcomes in several major brain diseases such as Depression, Alzheimer's disease, Parkinson's disease, Autism, and Aphasia through clinical trials jointly carried out with several top-tier hospitals.